Recent work by Stefan ten Eikelder et al. has shown that improved benefit in TCP/NTCP can be expected for a substantial number of patients through employment of the OSRT (optimal stopping in radiation therapy) paradigm, even in cases of relatively high uncertainties.
Read more: ESTRO newsletter, PMB publication
